Integrative analysis of genome-wide DNA methylation and single-nucleotide polymorphism identified ACSM5 as a suppressor of lumbar ligamentum flavum hypertrophy

• Published in: Arthritis research & therapy Vol. 23; no. 1; pp. 251 - 16
• Main Authors: Cao, Yanlin, Zhan, Yenan, Qiu, Sujun, Chen, Zhong, Gong, Kaiqin, Ni, Songjia, Duan, Yang
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 30.09.2021; BioMed Central; BMC
• Subjects: ACSM5; Analysis; Arthritis; Care and treatment; Cell fibrosis; Coenzyme A Ligases; Collagen; DNA (Cytosine-5-)-Methyltransferase 1; DNA methylation; DNA Methylation - genetics; Epigenetics; Gene expression; Genetic aspects; Genome-wide DNA methylation; Genomes; Humans; Hypertrophy - genetics; Hypertrophy of ligamentum flavum; Ligaments; Ligamentum Flavum - metabolism; Lumbar Vertebrae; Older people; Polymorphism; Polymorphism, Single Nucleotide; Single-nucleotide polymorphism; Spinal diseases; Spinal Stenosis - genetics; Spinal Stenosis - metabolism; Vertebrae; China; ACSM5; Single-nucleotide polymorphism; Genome-wide DNA methylation; Hypertrophy of ligamentum flavum; Cell fibrosis
• ISSN: 1478-6362; 1478-6354; 1478-6362
• DOI: 10.1186/s13075-021-02625-5

Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing to an abnormal pressure on spinal nerves. Previous studies revealed HLF might be caused by fibrosis, inflammatory, and other bio-pathways. However, a global analysis of HLF is needed severely. A genome-wide DNA methylation and single-nucleotide polymorphism analysis were performed from five LDD patients with HLF and five LDD patients without HLF. Comprehensive integrated analysis was performed using bioinformatics analysis and the validated experiments including Sanger sequencing, methylation-specific PCR, qPCR and ROC analysis. Furthermore, the function of novel genes in ligamentum flavum cells (LFCs) was detected to explore the molecular mechanism in HLF through knock down experiment, overexpression experiment, CCK8 assay, apoptosis assay, and so on. We identified 69 SNP genes and 735 661 differentially methylated sites that were enriched in extracellular matrix, inflammatory, and cell proliferation. A comprehensive analysis demonstrated key genes in regulating the development of HLF including ACSM5. Furthermore, the hypermethylation of ACSM5 that was mediated by DNMT1 led to downregulation of ACSM5 expression, promoted the proliferation and fibrosis, and inhibited the apoptosis of LFCs. This study revealed that DNMT1/ACSM5 signaling could enhance HLF properties in vitro as a potential therapeutic strategy for HLF.